Skip to main content

Closed

TYRA: Tyra Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-36.3%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio20.49×

Tyra Biosciences, Inc.

TYRANASDAQ Global Select·USD·Closed

Tyra Biosciences, Inc.

TYRANASDAQ·USD·Closed

$31.88

−3.57%

$31.88

−$1.18 (3.57%)

52W Range

71thpctl

Volume

0.87×avg

Mkt Cap

1.90BUSD

P/E

-14.6TTM

Div Yield

–ann

52W Range

71thpctl

Volume

0.87×avg

Market Cap

1.90BUSD

P/E Ratio

-14.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings